COPMAN: A Novel High-Throughput and Highly Sensitive Method to Detect Viral Nucleic Acids Including SARS-CoV-2 RNA in Wastewater

33 Pages Posted: 2 Jul 2022

See all articles by Yuka Adachi Katayama

Yuka Adachi Katayama

Shionogi & Co. Ltd. - Shionogi Pharmaceutical Research Center

Shin Hayase

Shionogi & Co. Ltd. - Shionogi Pharmaceutical Research Center

Yoshinori Ando

Shionogi & Co. Ltd. - Shionogi Pharmaceutical Research Center

Tomohiro Kuroita

Shionogi & Co. Ltd. - Shionogi Pharmaceutical Research Center

Kazuya Okada

affiliation not provided to SSRN

Ryo Iwamoto

Shionogi & Co. Ltd.

Toru Yanagimoto

Shionogi & Co. Ltd. - Shionogi Pharmaceutical Research Center

Masaaki Kitajima

Hokkaido University - Faculty of Engineering

Yusaku Masago

Shionogi & Co. Ltd. - Shionogi Pharmaceutical Research Center

Abstract

During the COVID-19 pandemic, wastewater-based epidemiology (WBE) attracted attention as an objective and comprehensive indicator of community infection that does not require individual inspection. Although several SARS-CoV-2 detection methods from wastewater have been developed, there are obstacles to their social implementation. In this study, we developed the COPMAN (Coagulation and Proteolysis method using Magnetic beads for detection of Nucleic acids in wastewater), an automatable method that can concentrate and detect multiple types of viruses from a limited volume (~10 ml) of wastewater. The COPMAN consists of a high basicity polyaluminum chloride (PAC) coagulation process, magnetic bead-based RNA purification, and RT-preamplification, followed by qPCR. A series of enzymes exhibiting a high tolerance to PCR inhibitors derived from wastewater was identified and employed in the molecular detection steps in the COPMAN. We compared the detectability of viral RNA from 10-ml samples of virus-spiked (heat-inactivated SARS-CoV-2 and intact RSV) or unspiked wastewater by the COPMAN and other reference methods (PEG-qPCR, UF-qPCR, and EPISENS-S). The COPMAN was the most efficient for detecting spiked viruses from wastewater, detecting the highest level of pepper mild mottle virus (PMMoV), a typical intrinsic virus in human stool, from wastewater samples. The COPMAN also successfully detected indigenous SARS-CoV-2 RNA from 12 samples of wastewater at concentrations of 2.2 × 104 to 5.4 × 105 copies/L, during initial stages of an infection wave in the right and the left bank of the Sagami River in Japan (0.65 to 11.45 daily reported cases per 100,000 people). These results indicate that the COPMAN is suitable for detection of multiple pathogens from small volume of wastewater in automated stations.

Note:
Funding Information: This study was funded by Shionogi & Co., Ltd.

Conflict of Interests: Yuka Adachi-Katayama, Shin Hayase, Yoshinori Ando, Tomohiro Kuroita, Kazuya Okada, Ryo Iwamoto, Toru Yanagimoto, and Yusaku Masago are employees of Shionogi & Co., Ltd. Masaaki Kitajima received research funding from AdvanSentinel Inc. and Shionogi & Co., Ltd. and patent royalties from Shionogi & Co., Ltd.

Keywords: Wastewater-based epidemiology, COVID-19, Sewage, Environmental surveillance, Automation, PCR

Suggested Citation

Katayama, Yuka Adachi and Hayase, Shin and Ando, Yoshinori and Kuroita, Tomohiro and Okada, Kazuya and Iwamoto, Ryo and Yanagimoto, Toru and Kitajima, Masaaki and Masago, Yusaku, COPMAN: A Novel High-Throughput and Highly Sensitive Method to Detect Viral Nucleic Acids Including SARS-CoV-2 RNA in Wastewater. Available at SSRN: https://ssrn.com/abstract=4150588 or http://dx.doi.org/10.2139/ssrn.4150588

Yuka Adachi Katayama

Shionogi & Co. Ltd. - Shionogi Pharmaceutical Research Center ( email )

Shin Hayase

Shionogi & Co. Ltd. - Shionogi Pharmaceutical Research Center ( email )

Yoshinori Ando

Shionogi & Co. Ltd. - Shionogi Pharmaceutical Research Center ( email )

Tomohiro Kuroita

Shionogi & Co. Ltd. - Shionogi Pharmaceutical Research Center ( email )

Kazuya Okada

affiliation not provided to SSRN ( email )

Ryo Iwamoto

Shionogi & Co. Ltd. ( email )

Toru Yanagimoto

Shionogi & Co. Ltd. - Shionogi Pharmaceutical Research Center ( email )

Masaaki Kitajima

Hokkaido University - Faculty of Engineering ( email )

Yusaku Masago (Contact Author)

Shionogi & Co. Ltd. - Shionogi Pharmaceutical Research Center ( email )

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
103
Abstract Views
453
Rank
572,948
PlumX Metrics